Following the successful float of Virtus Health last year, Monash IVF Group is currently one of the IPO's being marketed to Australian investors

Following the successful float of Virtus Health last year, Monash IVF Group is currently one of the IPO's being marketed to Australian investors. David Allingham analyst at small company specialist Eley Griffiths Group says it is one worth keeping an eye on. Monash IVF Group is an IPO we are working on and operates in the field of fertility services in Australia and Malaysia. At a 15% discount to Virtus Health (VRT) we think the stock is priced appropriately. Monash is a Victorian centric business and has plans to grow a larger presence in NSW, QLD and Malaysia. Forecast EPS growth of 18% in the 2015 looks achievable and will be supported by a more affordable low intervention IVF offering which VRT has pioneered.